• AKVANO® expand_more
  • Pharma expand_more
  • Business scope expand_more
  • Company expand_more
    • About expand_more
    • Management expand_more
    • CEO – letter expand_more
  • Investors expand_more
    • Investors expand_more
    • Investerare expand_more
  • Media expand_more
logo
  • AKVANO® expand_more
  • Pharma expand_more
  • Business scope expand_more
  • Company expand_more
    • About expand_more
    • Management expand_more
    • CEO – letter expand_more
  • Investors expand_more
    • Investors expand_more
    • Investerare expand_more
  • Media expand_more
Home / IR kontakt / Pressmeddelanden / Enskilt pressmeddelande
  • IR kontakt
  • Företrädesemission 2024
  • Pressmeddelanden
  • Finansiella rapporter
  • Finansiell kalender
  • Bolagsstyrning
    • Bolagsstämma
    • Styrelse
    • Ledning
    • Certifierad rådgivare
  • Aktien
    • Aktieägare
    • Incitamentsprogram
  • Börsintroduktion & prospekt
    • TO1
  • Presentationer
  • Prenumerera
Investor menu
  • IR kontakt
  • Företrädesemission 2024
  • Pressmeddelanden
  • Finansiella rapporter
  • Finansiell kalender
  • Bolagsstyrning
    • Bolagsstämma
    • Styrelse
    • Ledning
    • Certifierad rådgivare
  • Aktien
    • Aktieägare
    • Incitamentsprogram
  • Börsintroduktion & prospekt
    • TO1
  • Presentationer
  • Prenumerera
logo

Technology

The AKVANO® platform

Pharma applications

Investors

Investor relations

Pressreleases

Business scope

Company

About

Management

Press

Contact

Contact page

info@lipidor.se

 

The information on this website is of general information nature and is not intended to replace personal medical advice from doctors and other healthcare professionals. Lipidor’s pharma products are investigational drugs and are not approved for commercial use.

Privacy policy

©2024 Lipidor AB. All rights reserved.